WHITNEY HUNTER: Open Payments
NPI 1164842514 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,085 in 50 payments from 13 companies in 2025. Trend: 2023 $728 · 2024 $1,098 · 2025 $1,085
Food & beverage: $1,085
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $254 |
| ABBVIE INC. | 9 | $233 |
| Daiichi Sankyo Inc. | 6 | $133 |
| Stemline Therapeutics Inc. | 6 | $113 |
| Merck Sharp & Dohme LLC | 4 | $82 |
| Astellas Pharma US Inc | 5 | $73 |
| Lilly USA, LLC | 4 | $59 |
| Eisai Inc. | 1 | $31 |
| Genentech USA, Inc. | 1 | $23 |
| TerSera Therapeutics LLC | 1 | $23 |
Products named: ELAHERE, Enhertu, LYNPARZA, Orserdu, KEYTRUDA, Veozah, VERZENIO, Lenvima.
Industry payments across OK — which companies pay providers there.
